Latest filings (excl ownership)
15-12B
Securities registration termination
22 Feb 13
6-K
Current report (foreign)
21 Feb 13
F-10POS
Automatic registration of securities (post-effective amendment, Canada)
15 Feb 13
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Feb 13
25-NSE
Exchange delisting
12 Feb 13
25-NSE/A
Exchange delisting (amended)
12 Feb 13
6-K
Gilead Sciences Completes Acquisition of Ym Biosciences
8 Feb 13
6-K
YM BioSciences Reports Operational and Financial Results for the Second Quarter of Fiscal 2013
7 Feb 13
6-K
Current report (foreign)
7 Feb 13
6-K
Current report (foreign)
5 Feb 13
6-K
YM BioSciences Shareholders Approve Plan of Arrangement with Gilead Sciences
31 Jan 13
6-K
Current report (foreign)
18 Jan 13
6-K
Notice of Special Meeting of Shareholders
10 Jan 13
6-K
YM BioSciences Announces Record Date for Previously Announced Plan of Arrangement
21 Dec 12
6-K
Gilead Sciences to Acquire Ym Biosciences
12 Dec 12
6-K
Current report (foreign)
10 Dec 12
6-K
Annual Meeting of Shareholders
3 Dec 12
6-K
YM BioSciences Reports Divestiture of Nimotuzumab Assets by CIMYM
3 Dec 12
6-K
YM BioSciences Announces Election of Dr. Kapil Dhingra to its
21 Nov 12
6-K
YM BioSciences Reports Operational and Financial Results for the First Quarter of Fiscal 2013
9 Nov 12
6-K
Current report (foreign)
9 Nov 12
6-K
Current report (foreign)
5 Nov 12
6-K
YM BioSciences Reports CYT387 Phase I/II Results Selected for Oral
11 Oct 12
6-K
Current report (foreign)
10 Oct 12
40-F
2012 FY
Annual report (Canada)
21 Sep 12
6-K
YM BioSciences Reports Fiscal 2012 Operational and Financial Results
21 Sep 12
6-K
Current report (foreign)
21 Sep 12
SUPPL
Supplemental materials (foreign)
25 May 12
6-K
Current report (foreign)
14 May 12
6-K
Report of Foreign Issuer
11 May 12
6-K
Current report (foreign)
2 Mar 12
6-K
YM BioSciences Raises US$80.5 Million from Public Offering
29 Feb 12
6-K
Current report (foreign)
24 Feb 12
6-K
YM BioSciences Prices $70 Million Public Offering of Common Shares
24 Feb 12
6-K
YM BioSciences Announces Proposed Public Offering of Common Shares
24 Feb 12
FWP
Free writing prospectus
24 Feb 12
SUPPL
Supplemental materials (foreign)
24 Feb 12
SUPPL
Supplemental materials (foreign)
23 Feb 12
6-K
Current report (foreign)
9 Feb 12
6-K
YM BioSciences Reports Operational and Financial Results for the Second Quarter of Fiscal 2012
9 Feb 12
Latest ownership filings